New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 18, 2014
20:25 EDTHD, HD, MDT, MDT, TJX, TJX, DKS, DKS, RDEN, RDEN, NNA, NNA, AMWD, AMWDNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Home Depot (HD), consensus $1.45; Medtronic (MDT), consensus 92c; TJX Companies (TJX), consensus 73c; Dick's Sporting Goods (DKS), consensus 65c; Elizabeth Arden (RDEN), consensus (34c); Navios Maritime Acquisition (NNA), consensus (1c); American Woodmark (AMWD), consensus 43c.
News For HD;MDT;TJX;DKS;RDEN;NNA;AMWD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 10, 2016
09:32 EDTTJXTJX upgraded to Buy from Neutral at Buckingham
Subscribe for More Information
07:38 EDTNNANavios Acquisition reports Q4 EPS 13c, consensus 13c
Reports Q4 revenue $76.69M, consensus $76.36M.
February 9, 2016
10:01 EDTMDTMedtronic: First patient treated with Valiant TAAA stent graft system in study
Subscribe for More Information
February 8, 2016
14:56 EDTMDTDexCom selloff overdone, based on misinformation, says Cowen
Subscribe for More Information
February 5, 2016
09:12 EDTMDTMedtronic reports results from retrospective analysis of iPro2 Professional CGM
Subscribe for More Information
08:05 EDTMDTMedtronic receives FDA approval for MRI CRT-D
Medtronic announced that it has received FDA approval for the first and only magnetic resonance imaging, or MRI, conditional cardiac resynchronization therapy defibrillators, or CRT-Ds, for the treatment of heart failure. The Medtronic Amplia MRI Quad CRT-D SureScan and Compia MRI Quad CRT-D SureScan systems are approved for MRI scans on any part of the body without positioning restrictions. Now, patients in the U.S. who receive these devices, which help treat their heart failure and reduce their risk of sudden cardiac arrest, have access to MRI scans if and when they need them. Both CRT-D systems will be commercially available in the coming months.
February 4, 2016
16:18 EDTRDENElizabeth Arden reports Q2 adjusted EPS 10c
Subscribe for More Information
February 3, 2016
19:47 EDTHDHome Depot to hire 2,000 employees in Massachusetts, Boston Globe says
Subscribe for More Information
07:35 EDTHDHome Depot hiring over 80,000 positions for spring
Home Depot is hiring more than 80,000 associates nationwide to ensure its stores are staffed for the company's busiest selling season.
February 2, 2016
10:00 EDTTJXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: DuPont Fabros (DFT) upgraded to Buy from Hold at Evercore ISI... GOL Linhas (GOL) upgraded to Neutral from Sell at Goldman... Integrated Device (IDTI) upgraded to Outperform from Neutral at Wedbush... Julius Baer (JBAXY) upgraded to Hold from Sell at Deutsche Bank... Kohl's (KSS) upgraded to Buy from Neutral at Buckingham... Mattel (MAT) upgraded on positive catalysts at Stifel... Mitsubishi sees limited downside for Tableau (DATA), ups to Neutral ... Morgan Stanley (MS) upgraded to Outperform from Neutral at Macquarie... Netflix (NFLX) upgraded to Overweight from Neutral at Piper Jaffray... Realty Income (O) upgraded to Equal Weight from Underweight at Morgan Stanley... TJX (TJX) upgraded to Outperform from Market Perform at BMO Capital.
09:46 EDTTJXTJX upgraded on lower costs at BMO Capital
Subscribe for More Information
09:34 EDTTJXTJX initiated with an Outperform at Wolfe Research
Target $82.
06:02 EDTTJXTJX upgraded to Outperform from Market Perform at BMO Capital
February 1, 2016
10:02 EDTMDTMedtronic announced CE Mark, commercial launch for Resolute Onyx expansion
Medtronic announced the recent CE Mark and commercial launch for an expanded size matrix of the Resolute Onyx DES, a next generation drug-eluting stent that is now available in 4.5mm and 5.0mm diameter sizes. The CE Mark also approved several new product indications including treatment of left main vessels and small vessels. Many coronary vessels are large in diameter of which a sub-set are left main, and now physicians can treat these large vessels with optimally sized stents that provide appropriate drug concentration. Resolute Onyx is the first DES available in these sizes among major manufacturers, offering the broadest size matrix to optimize the treatment of complex clinical scenarios. The Resolute Onyx DES is not commercially available in the United States.
08:55 EDTTJXTJX names Ernie Herrman as CEO; Carol Meyrowitz becomes executive chairman
Subscribe for More Information
08:54 EDTTJXTJX names Ernie Herrman as CEO; Carol Meyrowitz becomes executive chairman
08:05 EDTMDTMedtronic acquires Bellco
Medtronic announced it acquired privately-held Bellco, a pioneer in hemodialysis treatment solutions. Bellco's portfolio bolsters Medtronic's legacy renal access business and will be a foundational component of the company's recently formed Renal Care Solutions business. The Bellco transaction is expected to meet Medtronic's long-term financial metrics for acquisitions. Medtronic expects the net impact from the transaction to be earnings neutral in FY16 and neutral to accretive to earnings thereafter.
January 29, 2016
16:25 EDTMDTMedtronic to present transcatheter pacing data to FDA
Subscribe for More Information
January 27, 2016
11:20 EDTDKSBed Bath & Beyond slips after Citi, Keybanc both say sell
Home goods retailer Bed Bath & Beyond (BBBY) is declining in late morning trading after being downgraded to Sell-equivalent ratings at both Keybanc and Citi. WHAT'S NEW: KeyBanc analyst Bradley Thomas downgraded Bed Bath & Beyond to Underweight from Sector Weight after his firm's work on housing showed growth has slowed. The analyst noted that the home furnishings sector is growing increasingly competitive, and he took a more cautious view on Hardline retailers whose growth is predicated primarily on same-store sales. Thomas kept a $35 price target on shares of Bed Bath & Beyond. Citi analyst Kate McShane downgraded Bed Bath & Beyond to Sell from Neutral on expectations the retailer's earnings will continue to decline over the next two years. McShane also noted that competition in home furnishings remains intense, while Bed Bath's e-commerce operations continue to be unprofitable. McShane cut her price target for the shares to $37 from $51. OTHERS TO WATCH: The analysts, in their respective notes, also opined on Bed Bath & Beyond's peers. Keybanc's Thomas downgraded Haverty Furniture (HVT) and Pier 1 Imports (PIR) to Sector Weight from Overweight. Meanwhile, Citi's McShane recommended a pair trade of long Dick's Sporting Goods (DKS), which the firm is Overweight on due to valuation, and short Bed Bath & Beyond. PRICE ACTION: Shares of Bed Bath & Beyond are down 1.6% to $43.34, while Haverty Furniture and Pier 1 Imports are down 3.8% and 3.9%, respectively. Dick's Sporting Goods, meanwhile, is down 0.7% to $37.84.
06:46 EDTDKSBed Bath & Beyond downgraded to Sell from Neutral at Citi
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use